Search research articles
Contact Us
Filters
Showing results (361-370 of 388) with videos related to
Page
of 39
Sort By:
The Journal of Allergy and Clinical Immunology
|
January 9, 2023
Evidence that oncostatin M synergizes with IL-4 signaling to induce TSLP expression in chronic rhinosinusitis with nasal polyps
Bao-Feng Wang, Ping-Ping Cao, James E Norton, et al.
Journal of Medicinal Chemistry
|
March 6, 2008
Design, synthesis, and SAR of new pyrrole-oxindole progesterone receptor modulators leading to 5-(7-fluoro-3,3-dimethyl-2-oxo-2,3-dihydro-1H-indol-5-yl)-1-methyl-1H-pyrrole-2-carbonitrile (WAY-255348)
Andrew Fensome, William R Adams, Andrea L Adams, et al.
The Journal of Allergy and Clinical Immunology
|
October 9, 2025
Effects of type 3 and neutrophilic inflammation on type 2 chronic rhinosinusitis with nasal polyps
Aiko Oka, Aiko I Klingler, Masanori Kidoguchi, et al.
International Forum of Allergy & Rhinology
|
April 1, 2022
Use of intraoperative frontal sinus mometasone-eluting stents decreased interleukin 5 and interleukin 13 in patients with chronic rhinosinusitis with nasal polyps
Alexander L Schneider, Samuel D Racette, Anthony K Kang, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
December 22, 2016
Chronic airway inflammation provides a unique environment for B cell activation and antibody production
S Feldman, R Kasjanski, J Poposki, et al.
The Journal of Allergy and Clinical Immunology
|
April 5, 2015
Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease
Kathryn L Pothoven, James E Norton, Kathryn E Hulse, et al.
The Journal of Allergy and Clinical Immunology
|
July 6, 2015
Increased expression of the epithelial anion transporter pendrin/SLC26A4 in nasal polyps of patients with chronic rhinosinusitis
Sudarshan Seshadri, Xiang Lu, Matthew R Purkey, et al.
Bone
|
March 4, 2009
A small molecule inhibitor of the Wnt antagonist secreted frizzled-related protein-1 stimulates bone formation
Peter V N Bodine, Barbara Stauffer, Helga Ponce-de-Leon, et al.
The Journal of Allergy and Clinical Immunology
|
November 14, 2025
Validation of a risk predictor score for early polyp recurrence in CRSwNP
Junqin Bai, Lutfiyya N Muhammad, Aditi Agarwal, et al.
The Journal of Allergy and Clinical Immunology
|
April 9, 2026
Heterogeneity and Clinical Relevance of Group 2 Innate Lymphoid Cells Subsets in Nasal Polyps
Masanori Kidoguchi, Naruhito Iwasaki, Julie A Poposki, et al.
Page
of 39
Search research articles
Search
Showing results (361-370 of 388) with videos related to
Sort By:
Page
of 39
The Journal of Allergy and Clinical Immunology
|
January 9, 2023
Evidence that oncostatin M synergizes with IL-4 signaling to induce TSLP expression in chronic rhinosinusitis with nasal polyps
Bao-Feng Wang, Ping-Ping Cao, James E Norton, et al.
Journal of Medicinal Chemistry
|
March 6, 2008
Design, synthesis, and SAR of new pyrrole-oxindole progesterone receptor modulators leading to 5-(7-fluoro-3,3-dimethyl-2-oxo-2,3-dihydro-1H-indol-5-yl)-1-methyl-1H-pyrrole-2-carbonitrile (WAY-255348)
Andrew Fensome, William R Adams, Andrea L Adams, et al.
The Journal of Allergy and Clinical Immunology
|
October 9, 2025
Effects of type 3 and neutrophilic inflammation on type 2 chronic rhinosinusitis with nasal polyps
Aiko Oka, Aiko I Klingler, Masanori Kidoguchi, et al.
International Forum of Allergy & Rhinology
|
April 1, 2022
Use of intraoperative frontal sinus mometasone-eluting stents decreased interleukin 5 and interleukin 13 in patients with chronic rhinosinusitis with nasal polyps
Alexander L Schneider, Samuel D Racette, Anthony K Kang, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
December 22, 2016
Chronic airway inflammation provides a unique environment for B cell activation and antibody production
S Feldman, R Kasjanski, J Poposki, et al.
The Journal of Allergy and Clinical Immunology
|
April 5, 2015
Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease
Kathryn L Pothoven, James E Norton, Kathryn E Hulse, et al.
The Journal of Allergy and Clinical Immunology
|
July 6, 2015
Increased expression of the epithelial anion transporter pendrin/SLC26A4 in nasal polyps of patients with chronic rhinosinusitis
Sudarshan Seshadri, Xiang Lu, Matthew R Purkey, et al.
Bone
|
March 4, 2009
A small molecule inhibitor of the Wnt antagonist secreted frizzled-related protein-1 stimulates bone formation
Peter V N Bodine, Barbara Stauffer, Helga Ponce-de-Leon, et al.
The Journal of Allergy and Clinical Immunology
|
November 14, 2025
Validation of a risk predictor score for early polyp recurrence in CRSwNP
Junqin Bai, Lutfiyya N Muhammad, Aditi Agarwal, et al.
The Journal of Allergy and Clinical Immunology
|
April 9, 2026
Heterogeneity and Clinical Relevance of Group 2 Innate Lymphoid Cells Subsets in Nasal Polyps
Masanori Kidoguchi, Naruhito Iwasaki, Julie A Poposki, et al.
Page
of 39